AlthoTech Consulting Inc. Pharmaceutical and Biotechnology Clinical Consulting
Email:;     Tel: 647 515 5314

CMC Management  •  QP Services  •  Clinical Packaging  • Regulatory Submissions

Company Overview

AlthoTech was founded in 2000 by Peter Tomlinson PhD, MBA, who is a senior pharmaceutical executive with 30+ years product development experience in the brand and generic sectors.

Prior to forming AlthoTech, his focus was strategic management. As Director at Glaxo Canada he managed a dynamic R&D and operations organization; as General Manager, with full P&L responsibility, for Taro Pharmaceuticals he managed a rapidly growing, operating company; and as President at Supratek Pharma he led an emerging R&D biopharmaceutical company.

Since 1987 Peter has been a QP. He is also a Qualified Pharmaceutical Lead auditor and has audited extensively in North America and Asia.

AlthoTech’s services are in two areas:


Recent clinical projects include managing the CMC programme through to filing of:

Drugs included small molecules, antisense and a biological extract. Dosage forms included IV solutions, oral solids and a rectal enema.

Recent clients include:

> Human Genome Sciences Inc. (US)                  > PurGenesis Technologies Inc. (Canada)

> Cytonet GmbH & Co. KG. (Germany)                > Receptor Therapeutics Inc. (Canada)

> Aegera Therapeutics Inc. (Canada)                  > LymphoSign Inc. (Canada)


Recent QP projects include:

Recent QP clients include:

> Sharp Clinical Services (UK) Ltd. (UK)                > Systems Biology UK Limited (UK)

> Biotec Services International Ltd. (UK)              > Inimex Pharmaceuticals Inc. (UK)

> Nextpharma GmbH. (Germany)                             > Cytonet GmbH & Co. KG. (Germany)